FDA Approved: FOLOTYN — Supplemental Application (Acrotech Biopharma Inc)

View source ↗

Summary

FDA approved a supplemental application for FOLOTYN (pralatrexate) submitted by Acrotech Biopharma Inc. The approval relates to its use in the treatment of peri…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peripheral T-cell Lymphoma

Drugs mentioned

• Folotyn (pralatrexate)

Snippet

SUPPL AP for FOLOTYN (PRALATREXATE)